HyCyte® | 海星生物

产品名称：4T1细胞hCCDC80基因过表达稳转细胞株

产品货号：CGSC-M31141

基因名称：hCCDC80[NM_199511.3，2853bp]

基因ID：151887

转导方法：转座子

转录本：NM_199511.3，2853bp

抗性基因：Puro

荧光基因：EGFP

验证方式：qPCR

克隆类型：Poolcells

靶细胞名称：小鼠乳腺癌细胞

靶细胞简称：4T1

种属来源：小鼠

组织来源：乳腺

疾病特征：乳腺癌

细胞形态：上皮细胞样

生长特性：贴壁生长

培养体系：RPMI-1640+10%FBS+1%P/S

配套培养基货号：TCM-G705

传代比例：1:3-1:6，每2-3天换液一次

倍增时间：48-72 h

培养条件：气相：95%空气+5%CO₂，温度：37℃

冻存条件：60%基础培养基+30%FBS+10%DMSO，液氮储存

质量检测：细菌、真菌、支原体检测均为阴性

参考文献：

Pulaski BA, et al. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma. Cancer Immunol. Immunother. 49: 34-45, 2000. PubMed: 10782864.

Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 58: 1486-1493, 1998. PubMed: 9537252.

Pulaski BA, et al. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Cancer Res. 60: 2710-2715, 2000. PubMed: 10825145.

Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52: 1399-1405, 1992. PubMed: 1540948.

收货当天如何处理细胞？

收到细胞后请务必仔细阅读产品资料，了解细胞相关信息，如贴壁特性 (贴壁/悬浮/半贴壁半悬浮)、细胞形态、培养体系、传代比例和换液频率等。